Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study

By sjmartinez • February 23, 2024

Meng M, Wei R, Wu Y, Zeng R, Luo D, Ma Y, Zhang L, Huang W, Zeng H, Leung FW, Qiu X, Sha W, Chen H. Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study. EClinicalMedicine. 2024 Feb 17;69:102500. doi: 10.1016/j.eclinm.2024.102500. PMID: 38389713; PMCID: PMC10882104.

Tags: coronavirus disease 2019, covid-19, Digestive Diseases, Epidemiological study, Publications, Respiratory diseases, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2

Cost effectiveness of hepatitis C direct acting agents

Shetty A, Lee M, Valenzuela J, Saab S. Cost effectiveness of hepatitis C direct acting agents. Expert Rev Pharmacoecon Outcomes Res. 2024 Apr 26. doi:[...]

Diet and the gut microbiome in patients with Parkinson’s disease

Kwon D, Zhang K, Paul KC, Folle AD, Del Rosario I, Jacobs JP, Keener AM, Bronstein JM, Ritz B. Diet and the gut microbiome in[...]

Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota

Andréasson K, Olofsson T, Lagishetty V, Alrawi Z, Klaassens E, Holster S, Hesselstrand R, Jacobs JP, Wallman JK, Volkmann ER. Treatment for Rheumatoid Arthritis Associated[...]